1. Home
  2. Knowledge Base
  3. cavalier-king-charles-spaniel
  4. Eye Conditions in Senior Cavalier King Charles Spaniels: Dry Eye, Cataracts & Retinal Disease

Eye Conditions in Senior Cavalier King Charles Spaniels: Dry Eye, Cataracts & Retinal Disease

Cavalier King Charles Spaniels (CKCS) are beloved companions known for their gentle temperament and expressive eyes — but that big, soulful look also reflects a breed with important, breed-specific oc

By SeniorPetCare Research Published: July 6, 2026 Last updated: August 11, 2026

Quick Answer

Senior Cavalier King Charles Spaniels commonly develop keratoconjunctivitis sicca (dry eye), age-related cataracts, and progressive retinal disease (including PRA), causing tearing, corneal changes, lens opacity and gradual vision loss. Early diagnosis—Schirmer tear test, ophthalmic exam and retinal imaging—and prompt treatment (topical cyclosporine for KCS, cataract surgery when appropriate, ophthalmology referral) preserves comfort and vision.

Article Summary — Key Takeaways

Reading time: 5 minutes | 5 key points

  • Point 1: Breed-specific high risk of multiple eye diseases
  • Point 2: Routine Schirmer tear test screening in senior Cavaliers
  • Point 3: STT interpretation: normal ≥15 mm/min, borderline 10–15, KCS <10 mm/min
  • Point 4: Treat KCS early and refer progressive or surgical cases to a specialist
  • Point 5: Regular ophthalmic checks protect vision and quality of life

Overview

[Cavalier King Charles](https://seniorpet.org/knowledge/breed/cavalier-king-charles-spaniel "Senior Cavalier King Charles Spaniel Health Guide") Spaniels (CKCS) are beloved companions known for their gentle temperament and expressive eyes — but that big, soulful look also reflects a breed with important, breed-specific ocular vulnerabilities. As CKCS age, owners and veterinarians must remain vigilant for several eye conditions that either occur more commonly in the breed or have distinctive features in CKCS. Senior Cavaliers commonly face disease processes that can threaten comfort and vision: tear-film disorders (keratoconjunctivitis sicca, KCS), congenital syndromes that cause severe dry eye, cataracts (both hereditary and age-related), retinal dysplasia, corneal dystrophy, abnormal eyelash growth (distichiasis), and prolapse of the third eyelid gland (“cherry eye”).

This article focuses specifically on CKCS: how these diseases present in older Cavaliers, how they are diagnosed (including useful numerical thresholds such as Schirmer tear test values), treatment options (medical and surgical), when to refer to a specialist, and practical screening guidance to protect vision and [quality of life](https://seniorpet.org/knowledge/[siamese](https://seniorpet.org/knowledge/breed/siamese "Senior Siamese Cat Health Guide")-cat-quality-of-life "Quality of Life Assessment") in senior dogs.

> 📖 Recommended Reading: For the complete picture of senior pet health management, read [our guide to quality of life decisions](/knowledge/end-of-life-palliative-care) for detailed protocols, statistics, and actionable advice.

Key Statistics & Research Data

  • Overall ocular disorder prevalence in CKCS: 20.6% reported in the [Cavalier King Charles Spaniel](https://seniorpet.org/knowledge/breed/cavalier-king-charles-spaniel "Senior Cavalier King Charles Spaniel Health Guide") breed health surveys (UK Kennel Club breed survey data) — i.e., roughly 1 in 5 dogs had an owner/veterinary-reported eye problem across cohorts studied [1].
  • CKCS are overrepresented in breed-specific ocular databases for conditions including cataracts, retinal dysplasia, corneal dystrophy and distichiasis per the OFA/CHIC eye registry data (OFA breed summary tables show higher-than-average positive CERF/OFA findings for these diagnoses) [2].
  • Keratoconjunctivitis sicca (KCS) is a recognized predisposition in CKCS with Schirmer tear test (STT) thresholds: normal ≥ 15 mm/min; borderline 10–15 mm/min; KCS generally < 10 mm/min (often < 5 mm/min in severe disease) — STT is the screening test of choice for tear production [3].
  • Curly Coat / Dry Eye Syndrome (CCDES) in CKCS is a congenital, often severe disorder associated with an autosomal mutation in FAM83H identified in breed-focused genetic workups; affected pups show abnormal hair/coat, severe ocular surface disease and early corneal scarring/blindness in some cases [4].
  • Before cataract surgery in CKCS, electroretinography (ERG) is recommended if retinal disease is suspected because concurrent retinal dysplasia/degeneration (reported in CKCS) lowers the likelihood of visual improvement after phacoemulsification [5].
  • Phacoemulsification cataract surgery in dogs subject to appropriate selection (no advanced retinal dysfunction) yields vision-restoring success rates typically 80–90% in uncomplicated cases; rates fall when retinal disease is present — emphasize breed-specific pre-op screening [6].
  • Distichiasis and other eyelid/conformational problems frequently reported in CKCS may account for a significant portion of chronic corneal irritation complaints in older dogs; minimally invasive procedures (electrolysis, cryotherapy, laser ablation) have high short-term success but recurrence rates vary by technique [2,7].
References:
  • The Kennel Club (UK) Cavalier King Charles Spaniel Health Survey summary (breed health reports).
  • OFA/CHIC Eye Database, breed summary reports (Cavalier King Charles Spaniel).
  • Gelatt KN. Veterinary Ophthalmology (textbook) — Schirmer tear test reference values.
  • Breed-specific genetic studies: Curly Coat / Dry Eye Syndrome in CKCS linked to a FAM83H mutation (genetic study; see breed genetics literature).
  • Veterinary ophthalmology review articles on cataract surgery and the importance of ERG prior to phacoemulsification.
  • Surgical outcome studies: canine cataract surgery (phacoemulsification) success rates in selected patients.
  • Review articles on distichiasis treatment outcomes.
  • (Notes: referenced studies and registries above are the primary sources used for breed-specific guidance; owners should ask their primary veterinarian for copies of any relevant papers or OFA/CHIC reports.)

    Why CKCS Owners Should Be Alert in Senior Years

    Several ocular problems in Cavaliers have a higher prevalence, earlier onset, or more severe course than in many other companion breeds. Senior CKCS often develop:

    • Progressive tear-film deficiency (KCS), which can be chronic, painful and lead to corneal ulcers if untreated.
    • Cataracts that may be age-related (senile) or hereditary; CKCS may also have lens/ocular conformational features that complicate cataract management.
    • Retinal abnormalities (retinal dysplasia, degenerative changes) that can be congenital or progressive; these directly impact the decision-making around cataract surgery.
    • Breed-linked congenital syndromes (CCDES) that may manifest in puppies but have lifelong consequences for corneal health and tear production.
    • Eyelid/conjunctival problems (distichiasis, entropion-like conformational irritation, cherry eye) that cause chronic corneal irritation and secondary disease.
    Early detection through screening, timely medical therapy, and judicious use of surgery can preserve vision and comfort in senior Cavaliers.

    Screening Recommendations (breed-specific)

    • Annual ophthalmic screening by a veterinarian trained in ocular disease is recommended for all CKCS, increasing to every 6–12 months for dogs with a prior abnormality. For breeding stock, follow OFA/CERF/CHIC guidelines for eye clearances; many CKCS breeding programs require annual CERF/OFA eye exams.
    • For senior CKCS with new ocular signs (redness, discharge, squinting, cloudy eye, bump on the eye, visual behavior changes), obtain a full ophthalmic exam including Schirmer tear test (STT), fluorescein stain, tonometry as indicated, slit-lamp examination and direct/indirect ophthalmoscopy.
    • Before considering cataract surgery in CKCS, obtain a complete ocular exam, gonioscopy if indicated, and electroretinography (ERG) when fundic abnormalities or retinal dysplasia/degeneration are suspected; ERG helps predict visual outcome after lens removal [5].
    • All owners of CKCS should be educated to report tearing, chronic mucoid discharge, rubbing at the eyes, corneal cloudiness, or behavioral signs of reduced vision promptly.

    Table: Common Ocular Conditions in Senior CKCS — quick reference

    | Condition | Approx. onset / age pattern in CKCS | Approx. breed-specific prevalence (reported/registry data) | Key diagnostic tests | Typical first-line treatments | When surgery indicated | |---|---:|---:|---|---|---| | KCS (keratoconjunctivitis sicca) | Middle-aged to senior; can be progressive | Part of reported ocular disease burden; KCS more common than in many breeds | Schirmer tear test (STT <10 mm/min diagnostic), cytology, fluorescein | Topical cyclosporine 0.2%–2% or tacrolimus; frequent lubricants; treat secondary infections | Parotid duct transposition for refractory severe KCS; conjunctival flaps for non-healing ulcers | | Curly Coat / Dry Eye Syndrome (CCDES) | Congenital — signs appear in puppies, but corneal disease persists into adulthood | Rare but severe in affected lines; genetic association (FAM83H) reported | Clinical exam, genetic testing (FAM83H mutation where available), STT often extremely low | Lifelong intensive lubrication; immunomodulators less effective in severe congenital cases | Rarely curative; supportive care; surgical interventions for corneal preservation (conjunctival flap) | | Cataracts (hereditary & age-related) | Middle-aged to senior; some juvenile hereditary forms exist | CKCS noted in registries for cataracts | Slit lamp, indirect ophthalmoscopy, ERG prior to surgery | Medical topical care for uveitis; anti-inflammatories; definitive = phacoemulsification ± IOL | Phacoemulsification when vision-limiting and retina functional on ERG | | Retinal dysplasia (multifocal/geographic) | Congenital forms detected in young dogs; geographic/malformation or acquired degeneration noted later | Reported in breed registries (breed predisposition) | Fundoscopy (mydriatic exam), optical coherence tomography (where available), ERG | No medical cure; manage secondary complications | Not typically surgical; ERG essential before cataract surgery | | Corneal dystrophy | Usually adult onset; may progress in seniors | Reported in CKCS registries | Slit lamp exam, fluorescein to exclude ulcer | Often none if non-vision-limiting; lubricants if symptomatic | Superficial keratectomy for vision-limiting deposits | | Distichiasis | Any age, often adult; can worsen with age | Frequently reported in CKCS | Eyelid exam with magnification, fluorescein to check corneal contact | Periodic epilation, topical lubricants | Cryotherapy, electrolysis, CO₂ laser or surgical excision for recurrent/persistent irritation | | Cherry eye (prolapsed nictitans gland) | Typically younger dogs but can be observed in adults | Seen in CKCS; if removed increases risk of KCS later | Clinical exam | Surgical replacement (pocket technique or anchor) is preferred | Always replace (do not excise) in CKCS if possible to preserve tear function |

    (Prevalence entries reflect registry and breed-survey findings indicating above-average ocular disease burden in CKCS; individual dog risk varies by lineage and age.)

    Keratoconjunctivitis Sicca (KCS) — CKCS specifics

    Presentation and significance

    • CKCS commonly present with chronic mucoid discharge, red conjunctiva, squinting, corneal vascularization and pigmentation. Tear deficiency can be primary (immune-mediated) or secondary to other causes; CKCS have a recognized predisposition to KCS.
    • Objective measurement: Schirmer tear test (STT). Normal tear production is generally ≥ 15 mm/min. KCS is typically defined as STT < 10 mm/min; severe cases often measure < 5 mm/min [3].
    Diagnosis
    • STT is essential. Cytology and bacterial culture may be useful for chronic, infected cases. Fluorescein staining rules out corneal ulceration.
    • In CKCS, repeat testing may be necessary to document progression.
    Medical treatment
    • Lifelong topical immunomodulators (cyclosporine 0.2–2% ophthalmic, commonly 0.2%–2% solution/ointment) or tacrolimus (0.03–0.1%) twice daily are standard; they increase tear production over weeks to months and treat the underlying immune-mediated inflammation.
    • Frequent ocular lubrication (artificial tears, gels at night) and short courses of topical antibiotics for secondary infection.
    • Monitor STT every 1–3 months initially; many CKCS require combination therapy and life-long medication.
    Surgical options
    • Parotid duct transposition (PDT) can be considered in refractory severe KCS in CKCS where medical therapy fails or quality of life is poor. PDT redirects saliva to the conjunctival fornix to substitute for tears — many dogs achieve comfortable corneal surfaces, but saliva can cause sticky discharge and dietary/care considerations.
    • Tarsorrhaphy or conjunctival (pedicle) flaps are reserves for non-healing ulcers or severely compromised corneas.
    When to refer
    • Any CKCS with STT persistently < 5–7 mm/min, non-healing corneal ulcers, or poor response to topical immunomodulation should be referred to a veterinary ophthalmologist to discuss PDT or other advanced therapies.

    Curly Coat / Dry Eye Syndrome (CCDES) and FAM83H mutation

    What it is

    • CCDES is a congenital syndrome described in CKCS lines that combines an abnormal hair/coating phenotype with severe congenital ocular surface disease and tear deficiency. Genetic studies in affected dogs have implicated a mutation in the FAM83H gene in at-risk lines [4].
    Clinical course
    • Signs commonly appear in puppies (abnormal coat, poor/absent tear production, early corneal ulceration and scarring). These dogs may progress to blindness due to corneal opacification and scarring if not aggressively managed early.
    • In senior CKCS, CCDES survivors may present with chronic severe corneal scarring and very low STT values despite therapy.
    Diagnosis and management
    • Genetic testing of breeding animals is recommended in lines where CCDES has been identified. If the mutation is known and a test is available, breeders should avoid producing affected puppies.
    • Management of affected dogs is largely supportive: aggressive lubrication, control of secondary infection, and corneal protective procedures. Traditional immunomodulators (cyclosporine) may be less effective in congenital glandular aplasia.
    • Surgical options such as conjunctival flaps or corneal grafting may be used to preserve globe integrity but rarely restore normal vision. Genetic counseling is essential to prevent propagation.

    Cataracts in CKCS

    Breed features

    • CKCS appear in registry data for cataract diagnoses and may have hereditary early-onset forms as well as age-related cataracts in seniors.
    • Because CKCS also have a nontrivial rate of retinal dysplasia/dysfunction, pre-surgical retinal assessment is especially important.
    Diagnosis and pre-op workup
    • Slit-lamp and indirect ophthalmoscopy will document cataract morphology and any fundic abnormalities that can be visualized. If the cataract is mature and fundoscopy limited, ERG is strongly recommended to evaluate retinal function prior to cataract surgery [5].
    • Tonometry and gonioscopy to evaluate for concurrent glaucoma are important.
    Treatment
    • Medical therapy is supportive (manage lens-induced uveitis with topical NSAIDs and/or steroids under veterinarian guidance) but does not restore vision.
    • Definitive treatment is phacoemulsification with intraocular lens implantation performed by a veterinary ophthalmic surgeon. In properly selected CKCS without advanced retinal dysfunction, reported vision restoration rates are favorable (80–90% in many series), but individual prognosis depends on retinal health and other comorbidities [6].
    When to operate
    • Indications include vision-limiting cataract when retinal function is intact on ERG and owner commitment to perioperative care exists. For CKCS with concurrent retinal dysplasia or degeneration, surgical benefits may be limited — candidacy must be assessed case-by-case with specialist input.

    Retinal Dysplasia (multifocal, geographic) in CKCS

    What it is

    • Retinal dysplasia in CKCS often manifests as multifocal retinal folds or geographic scarring. Congenital forms are present from early life; acquired degenerative changes can develop later.
    • Multifocal dysplasia may be an incidental finding with minimal vision impact; geographic dysplasia affecting the central tapetum or area centralis can reduce vision.
    Diagnosis
    • Fundoscopy is the primary diagnostic method. Optical coherence tomography (OCT) can define structural abnormalities. ERG assesses global retinal function and is particularly important in pre-cataract surgery evaluation to determine whether retina will support vision after lens removal.
    Management
    • There is no targeted medical therapy to reverse dysplasia. Management is focused on preventing secondary problems and making realistic surgical decisions (e.g., avoiding cataract surgery if ERG indicates poor retinal function).
    • Genetic counseling and registry reporting help reduce propagation in breeding lines.

    Corneal Dystrophy

    Presentation

    • Corneal dystrophy in CKCS typically presents as bilateral, symmetric, non-inflammatory crystalline or lipid deposits in the corneal stroma. These often do not cause pain but may cause visual impairment when central and extensive.
    Management
    • If asymptomatic and not vision-limiting, observation and lubrication as needed are appropriate.
    • For topical discomfort or vision impairment, superficial keratectomy or phototherapeutic keratectomy may be considered by a specialist.

    Distichiasis

    Presentation and diagnosis

    • Distichiasis (extra hairs emerging from meibomian gland orifices) is commonly reported in CKCS and can cause chronic corneal irritation, epiphora and secondary pigmentation or vascularization.
    • Diagnosis is by magnified eyelid exam; fluorescein staining checks for corneal damage.
    Treatment options
    • Epilation provides temporary relief but hairs often regrow.
    • Definitive options include cryotherapy, electrocautery/electrolysis, CO₂ laser ablation, or surgical excision of the aberrant follicle. Choice depends on the number/location of hairs and recurrence risk.

    Cherry Eye (prolapsed nictitans gland)

    CKCS considerations

    • Although cherry eye is more commonly a younger-dog problem, CKCS can develop nictitans gland prolapse at any age. Because CKCS are predisposed to KCS, surgical replacement (rather than gland excision) is strongly advised to preserve lacrimal function long-term.
    Preferred treatment
    • Surgical replacement (pocket technique or anchoring) is the recommended approach. Excision of the gland is discouraged in CKCS due to the increased lifelong risk of tear deficiency.

    Practical management pathway for a senior CKCS with an eye problem

  • Initial primary-care vet exam: STT, fluorescein, slit-lamp exam, menace/PLR testing, tonometry if glaucoma suspected. Treat acute pain/infection.
  • If STT < 10 mm/min — start topical immunomodulator (cyclosporine/tacrolimus) and lubricants; consider culture/cytology for chronic mucoid discharge. Recheck within 2–8 weeks.
  • If cataract/mature lens opacity found — refer for specialist evaluation including ERG and possible phacoemulsification discussion.
  • If corneal ulcer, non-healing erosion, or structural eyelid abnormality — refer to ophthalmologist early to prevent scarring and vision loss.
  • Genetic counseling/testing and breeder notification if congenital syndromes (CCDES) are suspected in any CKCS litter line.
  • When to Refer to a Veterinary Ophthalmologist

    • Suspected or confirmed vision loss, mature cataract, or cataract in a dog with fundus abnormalities.
    • STT persistently < 5 mm/min, refractory KCS, or repeated ulcers.
    • Severe corneal disease (deep ulcers, descemetocele), non-healing ulcers, or recurrent erosions.
    • Complex eyelid surgeries (distichiasis with deep follicle involvement, large cherry eye, entropion repair).
    • Pre-surgical assessments (cataract surgery candidacy, PDT consideration).
    Specialists offer advanced diagnostics (ERG, OCT), specialized surgeries (phacoemulsification, PDT), and long-term management plans.

    Communication with Breeders and Testing

    • CKCS owners and breeders should use OFA/CERF/CHIC eye testing and, where available, breed-relevant genetic tests (e.g., CCDES-associated markers) to guide breeding decisions. Avoid breeding dogs with progressive hereditary ocular diseases or dogs that produce affected offspring when genetic testing indicates a heritable risk.
    • Reporting diagnoses to registries helps refine prevalence data and reduce incidence over generations.

    Quality of life and cost considerations

    • Chronic KCS and corneal disease require life-long therapy in many CKCS; owners should be counseled on costs, daily medication schedules, and realistic expectations.
    • Cataract surgery is an investment (pre-op testing, surgery, intensive post-op care); outcomes in CKCS are strongly tied to retinal status and therefore thorough pre-op screening is essential to avoid futile procedures.

    Key Takeaways

    • CKCS have an above-average burden of ocular disease (overall prevalence ~20.6% in breed surveys); older dogs require regular eye monitoring [1,2].
    • Schirmer tear test is the essential screening tool for KCS (normal ≥ 15 mm/min; KCS typically < 10 mm/min); CKCS with KCS often need lifelong topical immunomodulators and lubricants [3].
    • Curly Coat / Dry Eye Syndrome (CCDES) is a breed-specific, congenital condition in CKCS linked to FAM83H mutations in affected lines; genetic testing and breeding management are key to prevention [4].
    • Cataract surgery (phacoemulsification) can restore vision in CKCS but only when retinal function is adequate — ERG is critical before surgery because retinal dysplasia/degeneration occurs in the breed [5,6].
    • Distichiasis and cherry eye are common CKCS eyelid issues — treat cherry eye with gland replacement (not excision) to reduce future KCS risk; treat distichiasis definitively if recurrent corneal irritation occurs [2,7].
    • Early referral to a veterinary ophthalmologist is recommended for refractory KCS, non-healing corneal ulcers, severe cataracts, or any CKCS with suspected retinal disease; proactive screening (annual CERF/OFA/CHIC eye checks) helps protect vision and guide breeding decisions.
    If you are the caregiver of a senior Cavalier showing any eye changes — redness, discharge, squinting, cloudiness, or changes in navigation — contact your veterinarian promptly for an STT and referral if indicated. Early diagnosis and breed-specific management make a real difference for comfort and vision in CKCS.

    For assistance obtaining OFA/CERF/CHIC reports or to discuss genetic testing options for your Cavalier’s lineage, ask your veterinarian to help coordinate testing and specialist referral.

    Frequently Asked Questions

    How can I tell if my senior Cavalier has dry eye (KCS) and what do Schirmer tear test values mean?

    Senior Cavaliers with dry eye often show thick, mucous discharge, frequent blinking or squinting, red or irritated eyes, and a dull corneal surface. A Schirmer tear test (STT) is used to measure tear production; values below roughly 10–15 mm/min are commonly considered abnormal and suggest KCS in dogs. Diagnosis is by STT plus an ophthalmic exam, and treatment in Cavaliers usually involves lifelong tear supplements and prescription topical immunomodulators (e.g., cyclosporine or tacrolimus) with regular rechecks.

    Are cataracts common in older Cavaliers and can they be treated successfully?

    Cavalier King Charles Spaniels are prone to both hereditary and age-related cataracts, which present as a cloudy lens and progressive vision loss or bumping into things. Cataracts are diagnosed on ophthalmic exam and sometimes imaging; cataract surgery (phacoemulsification with intraocular lens placement) can restore vision in many dogs but requires pre‑operative assessment of retinal health because Cavaliers are also at risk for retinal disease. Not every dog is a surgical candidate due to concurrent eye disease or systemic health, so discussion with a veterinary ophthalmologist is important.

    What retinal diseases affect senior Cavaliers and can vision loss from them be treated?

    Senior Cavaliers may develop retinal dysplasia or other inherited/degenerative retinal conditions that cause progressive vision loss, often first noticed as night blindness or hesitancy in low light. Diagnosis may include an ophthalmic exam and electroretinography (ERG) to assess retinal function; many inherited retinal degenerations have no curative medical treatment, though some inflammatory or secondary retinal conditions can be managed. Owners can help affected Cavaliers with environmental adaptations and the veterinary ophthalmologist can advise prognosis and supportive care.

    Related Articles

    • Cavalier King Charles Spaniel History: From Royal Courts to Modern Companion (cavalier-king-charles-spaniel) — The Cavalier King Charles Spaniel descends from small toy spaniels popular in Renaissance and 17th-century England, famously favored by King Charles II. Victorian breeding produced the shorter-faced King Charles Spaniel; early 20th-century enthusiasts revived the older, longer-muzzled type to create the modern Cavalier. Today Cavaliers are beloved affectionate companions with a gentle temperament and predispositions to heart and neurological conditions.
    • Cavalier King Charles Spaniel Physical Characteristics: Four Color Varieties & Breed Standard (cavalier-king-charles-spaniel) — Compact, graceful toy spaniels, Cavaliers stand about 12–13 inches (30–33 cm) at the withers and typically weigh 13–18 lb (6–8 kg). They have a flat skull, large dark round eyes, a moderate stop, tapered muzzle, long feathered ears and a silky, flat or slightly wavy coat with feathering on chest, legs and tail. Recognized colors: Blenheim, tricolor, ruby and black‑and‑tan.
    • Cavalier King Charles Spaniel Temperament & Behavior Changes in Senior Years (cavalier-king-charles-spaniel) — Cavalier seniors commonly show reduced activity, increased clinginess or irritability, sleep‑wake changes, disorientation and house‑soiling from canine cognitive dysfunction; concurrent myxomatous mitral valve disease (MMVD)—the breed’s leading cardiac condition and common cause of cardiac death—can cause exercise intolerance, coughing, restlessness or syncope, worsening behavior and quality of life; veterinary assessment is recommended. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/41442884/?utm_source=openai))
    • Cavalier King Charles Spaniel Lifespan: Statistics, Factors & How to Maximize Longevity (cavalier-king-charles-spaniel) — The average Cavalier King Charles Spaniel lives about 10–12 years (range ~9–14). Major lifespan threats include myxomatous mitral valve disease (MMVD), syringomyelia, and cancer. Maximize longevity with annual cardiac screening (auscultation and echocardiography if murmurs), weight and dental care, balanced nutrition, parasite control, regular veterinary exams, prompt neurologic evaluation, and choosing dogs from health‑tested breeders.
    • Senior Cavalier King Charles Spaniel Health: Complete Screening & Prevention Guide (cavalier-king-charles-spaniel) — For senior Cavalier King Charles Spaniels (generally ≥8 years): annual wellness exam plus CBC, chemistry, T4, urinalysis and blood pressure; dental cleaning with oral radiographs; cardiac auscultation every visit and echocardiogram if a murmur or every 6–12 months with known MMVD; neurologic/orthopedic and ophthalmic exams; thoracic radiographs as indicated. Maintain weight, a balanced senior diet, dental care and parasite prevention.
    • Mitral Valve Disease in Cavalier King Charles Spaniels: The Complete Guide to Diagnosis, Staging & Treatment (cavalier-king-charles-spaniel) — Mitral valve disease in Cavalier King Charles Spaniels is progressive myxomatous degeneration causing mitral regurgitation. Diagnosis uses auscultation, thoracic radiographs, echocardiography (to assess valve morphology, regurgitant volume and chamber size) and biomarkers (NT‑proBNP). Staging follows ACVIM (A–D). Management: asymptomatic monitoring; once heart failure develops, pimobendan, diuretics (furosemide), ACE inhibitors, sodium restriction and regular rechecks improve survival and quality of life.

    Explore more: Complete Senior cavalier-king-charles-spaniel Health Guide | Free AI Health Assessment

    Category: chronic disease | Species: dog | Read time: 5 minutes

    Topics: cavalier king charles spaniel, CKCS senior care, cavalier eye problems, dry eye KCS, curly coat syndrome

    Browse all articles | Free Health Assessment